Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Inhibrx Biosciences, Inc. (INBX) had Earnings per Share (EPS) (Basic) of $-9.04 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$1.30M |
|
$-140.06M |
|
-- |
|
$1.30M |
|
$136.32M |
|
$-135.03M |
|
$-5.03M |
|
$-140.05M |
|
$-140.05M |
|
$-140.06M |
|
$-140.06M |
|
$-140.06M |
|
$-140.06M |
|
$-135.03M |
|
$-132.54M |
|
15.49M |
|
15.49M |
|
|
Earnings per Share (EPS) (Basic) |
$-9.04 |
$-9.04 |
|
| Balance Sheet Financials | |
$132.83M |
|
$3.73M |
|
$13.65M |
|
$146.48M |
|
$33.80M |
|
$100.56M |
|
$104.69M |
|
$138.49M |
|
$7.99M |
|
$7.99M |
|
$7.99M |
|
14.58M |
|
| Cash Flow Statement Financials | |
$-129.79M |
|
$-0.03M |
|
$101.45M |
|
$152.60M |
|
$124.22M |
|
$-28.38M |
|
$11.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.93 |
|
-- |
|
-- |
|
0.93 |
|
12.58 |
|
100.00% |
|
-10386.54% |
|
-10386.54% |
|
-10195.54% |
|
-10773.31% |
|
-10773.46% |
|
$-129.82M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
7.34 |
|
49.70 |
|
-1752.22% |
|
-1752.22% |
|
-95.61% |
|
-129.02% |
|
$0.55 |
|
$-8.38 |
|
$-8.38 |
|